Revvity
Dr. Carl J. Christel is currently the Head of the US site at Revvity Gene Delivery GmbH, a position held since January 2023. Prior to this role, Dr. Christel served in various leadership capacities at SIRION Biotech GmbH from January 2013 to September 2023, including Vice President of US Operations and Global Marketing Director & Sales USA, with responsibilities encompassing sales, marketing, and customer project management. Dr. Christel's expertise is underpinned by a strong research background as a Post-Doc Scholar at The University of Iowa Health Care, focusing on molecular physiology and cardiology, and a PhD in Biology from Technische Universität München.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com